{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T17:00:57Z","timestamp":1784566857927,"version":"3.55.0"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"44","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,31]]},"abstract":"<jats:p>\n                    Uterine artery embolization (UAE) is an effective treatment for adenomyosis, but ovarian collateral supply can increase the risk of recurrence. This study aimed to explore the safety and efficacy of combined UAE and unilateral ovarian artery embolization (OAE) in adenomyosis patients with ovarian artery collateral supply exceeding 10% of ipsilateral uterine perfusion, particularly focusing on ovarian function. This single-center retrospective study was conducted at Fujian Maternity and Child Health Hospital from June 2021 to April 2023, including 23 eligible patients, with 18 completing the 12-month follow-up. The exposure was combined UAE\u2005+\u2005OAE treatment, with outcome variables including reproductive hormone levels, ovarian reserve function, and clinical symptom improvement. At 12 months, the median symptom severity score decreased by 79% (57\u219212, \u039445 [95%CI 38\u201352],\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;.001), quality of life score increased by 95% (40\u219278, \u039438 [32\u201344],\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;.001), and pain score (numerical rating scale) decreased by 71% (7\u21922, \u03945 [4\u20136],\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;.001). anti-M\u00fcllerian hormone transiently declined at 3 months (3.91\u21921.86\u2009ng\/mL, \u0394\u22122.05 [\u22122.41 to \u22121.69],\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.006) but recovered by 6 months (4.01\u2009ng\/mL) and remained stable at 12 months (4.18\u2009ng\/mL). Follicle-stimulating hormone, luteinizing hormone, and antral follicle count (AFC) remained stable (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&gt;.4), all patients resumed regular menses without menopausal symptoms, and no major complications were reported. In this small, single-center cohort of relatively young adenomyosis patients with significant ovarian artery collateral supply, combined UAE\u2005+\u2005OAE was associated with symptom improvement and no measurable impairment of ovarian reserve over 12 months. However, confirmation of the safety and efficacy of combined UAE\u2005+\u2005OAE in younger adenomyosis patients requires data from larger, multicenter cohorts and randomized trials.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000045656","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T17:01:48Z","timestamp":1763571708000},"page":"e45656","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and ovarian preservation of combined uterine and ovarian artery embolization in adenomyosis with significant collateral supply"],"prefix":"10.1097","volume":"104","author":[{"given":"Jianfeng","family":"He","sequence":"first","affiliation":[{"name":"Department of Vascular Surgery & Interventional Therapy, Fujian Maternity and Child Health Hospital, Fuzhou, Fujian Province, China"},{"name":"College of Clinical Medicine for Obstetrics and Gynecology and Pediatrics, Fujian Medical University, Fuzhou, Fujian Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2801-6795","authenticated-orcid":false,"given":"Tenghui","family":"Zhan","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery & Interventional Therapy, Fujian Maternity and Child Health Hospital, Fuzhou, Fujian Province, China"},{"name":"College of Clinical Medicine for Obstetrics and Gynecology and Pediatrics, Fujian Medical University, Fuzhou, Fujian Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260520","doi-asserted-by":"crossref","first-page":"94.e1","DOI":"10.1016\/j.ajog.2020.01.016","article-title":"Adenomyosis incidence, prevalence and treatment: United States population-based study 2006\u20132015.","volume":"223","author":"Yu","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"R2-20260520","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.jmig.2020.10.012","article-title":"A systematic review of adenomyosis: it is time to reassess what we thought we knew about the disease.","volume":"28","author":"Loring","year":"2021","journal-title":"J Minim Invasive Gynecol"},{"key":"R3-20260520","doi-asserted-by":"crossref","first-page":"089","DOI":"10.1055\/s-0040-1718920","article-title":"Epidemiology of adenomyosis.","volume":"38","author":"Upson","year":"2020","journal-title":"Semin Reprod Med"},{"key":"R4-20260520","doi-asserted-by":"crossref","first-page":"6027","DOI":"10.1038\/s41598-025-85823-4","article-title":"The clinical efficacy and influencing factors of uterine artery embolization in the treatment of different types of uterine adenomyosis.","volume":"15","author":"Wei","year":"2025","journal-title":"Sci Rep"},{"key":"R5-20260520","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.3390\/jpm13091385","article-title":"Our experience with hydrogel-coated trisacryl microspheres in uterine artery embolization for the treatment of symptomatic uterine fibroids and adenomyosis: a follow-up of 11 years.","volume":"13","author":"Tsikouras","year":"2023","journal-title":"J Pers Med"},{"key":"R6-20260520","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1080\/09513590.2016.1197200","article-title":"Adenomyosis: a systematic review of medical treatment.","volume":"32","author":"Pontis","year":"2016","journal-title":"Gynecol Endocrinol"},{"key":"R7-20260520","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.fertnstert.2018.01.013","article-title":"Role of medical therapy in the management of uterine adenomyosis.","volume":"109","author":"Vannuccini","year":"2018","journal-title":"Fertil Steril"},{"key":"R8-20260520","doi-asserted-by":"crossref","first-page":"102228","DOI":"10.1016\/j.jogoh.2021.102228","article-title":"Adenomyosis: an update regarding its diagnosis and clinical features.","volume":"50","author":"Bourdon","year":"2021","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"R9-20260520","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s10815-022-02476-2","article-title":"Adenomyosis and infertility.","volume":"39","author":"Moawad","year":"2022","journal-title":"J Assist Reprod Genet"},{"key":"R10-20260520","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/uog.24786","article-title":"Consensus on revised definitions of morphological uterus sonographic assessment (MUSA) features of adenomyosis: results of modified Delphi procedure.","volume":"60","author":"Harmsen","year":"2022","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R11-20260520","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.jvir.2015.04.026","article-title":"Uterine artery embolization for adenomyosis: percentage of necrosis predicts midterm clinical recurrence.","volume":"26","author":"Bae","year":"2015","journal-title":"J Vasc Interv Radiol"},{"key":"R12-20260520","doi-asserted-by":"crossref","first-page":"5707","DOI":"10.1007\/s00261-021-03255-w","article-title":"Ovarian arteries embolization in women with persistent symptoms following uterine arteries embolization for uterus fibroids.","volume":"46","author":"Ifergan","year":"2021","journal-title":"Abdom Radiol"},{"key":"R13-20260520","doi-asserted-by":"crossref","first-page":"243","DOI":"10.5114\/wiitm.2020.100713","article-title":"Clinical outcome and analysis of procedural failure during uterine artery chemoembolisation as a treatment of caesarean scar pregnancy.","volume":"16","author":"Pyra","year":"2020","journal-title":"Videosurgery Miniinvasive Tech"},{"key":"R14-20260520","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1055\/s-0043-1770713","article-title":"Update on endovascular therapy for fibroids and adenomyosis.","volume":"40","author":"Ozen","year":"2023","journal-title":"Semin Intervent Radiol"},{"key":"R15-20260520","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2214\/ajr.172.4.10587133","article-title":"Arterial anatomy of the female genital tract: variations and relevance to transcatheter embolization of the uterus.","volume":"172","author":"Pelage","year":"1999","journal-title":"AJR Am J Roentgenol"},{"key":"R16-20260520","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1148\/radiol.2441060796","article-title":"Uterine fibroid embolization: the utility of aortography in detecting ovarian artery collateral supply.","volume":"244","author":"White","year":"2007","journal-title":"Radiology"},{"key":"R17-20260520","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1007\/s00270-017-1618-0","article-title":"Ovarian artery embolization as a treatment for persistent ovarian remnant syndrome.","volume":"40","author":"Chan","year":"2017","journal-title":"Cardiovasc Intervent Radiol"},{"key":"R18-20260520","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jvir.2024.11.006","article-title":"Redistribution and embolization of a uterine fibroid with ovarian arterial supply using temporary bilateral ovarian artery microballoon occlusion.","volume":"36","author":"El Shamy","year":"2025","journal-title":"J Vasc Interv Radiol"},{"key":"R19-20260520","doi-asserted-by":"crossref","first-page":"100726","DOI":"10.1016\/j.tvir.2021.100726","article-title":"Uterine artery embolization for adenomyosis.","volume":"24","author":"Caridi","year":"2021","journal-title":"Tech Vasc Interv Radiol"},{"key":"R20-20260520","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1148\/radiol.2243011513","article-title":"Angiographic classification of ovarian artery\u2013to\u2013uterine artery anastomoses: initial observations in uterine fibroid embolization.","volume":"224","author":"Huang","year":"2002","journal-title":"Radiology"},{"key":"R21-20260520","doi-asserted-by":"crossref","first-page":"110183","DOI":"10.1016\/j.ejrad.2022.110183","article-title":"Nomogram for predicting the long-term outcomes of uterine artery embolization for adenomyosis.","volume":"148","author":"WenTao","year":"2022","journal-title":"Eur J Radiol"},{"key":"R22-20260520","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s42155-024-00468-0","article-title":"Evaluation of junctional zone differential and ratio as possible markers of clinical efficacy in uterine artery embolisation of adenomyosis.","volume":"7","author":"Turt\u00f3czki","year":"2024","journal-title":"CVIR Endovasc"},{"key":"R23-20260520","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00270-011-0254-3","article-title":"Uterine artery embolization to treat uterine adenomyosis with or without uterine leiomyomata: results of symptom control and health-related quality of life 40 months after treatment.","volume":"35","author":"Froeling","year":"2011","journal-title":"Cardiovasc Intervent Radiol"},{"key":"R24-20260520","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1007\/s00270-017-1686-1","article-title":"Uterine artery embolization for symptomatic adenomyosis: 7-year clinical follow-up using UFS-Qol questionnaire.","volume":"40","author":"de Bruijn","year":"2017","journal-title":"Cardiovasc Intervent Radiol"},{"key":"R25-20260520","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1016\/j.acra.2024.05.037","article-title":"Multi-machine learning model based on habitat subregions for outcome prediction in adenomyosis treated by uterine artery embolization.","volume":"31","author":"Jin","year":"2024","journal-title":"Acad Radiol"},{"key":"R26-20260520","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s00270-017-1703-4","article-title":"Cirse quality assurance document and standards for classification of complications: the cirse classification system.","volume":"40","author":"Filippiadis","year":"2017","journal-title":"Cardiovasc Intervent Radiol"},{"key":"R27-20260520","doi-asserted-by":"crossref","first-page":"1273966","DOI":"10.3389\/fendo.2023.1273966","article-title":"Anti-M\u00fcllerian hormone beyond an ovarian reserve marker: the relationship with the physiology and pathology in the life-long follicle development.","volume":"14","author":"Iwase","year":"2023","journal-title":"Front Endocrinol"},{"key":"R28-20260520","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/humupd\/dmt062","article-title":"The physiology and clinical utility of anti-M\u00fcllerian hormone in women.","volume":"20","author":"Dewailly","year":"2014","journal-title":"Hum Reprod Update"},{"key":"R29-20260520","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1080\/13645706.2017.1365728","article-title":"Anti-M\u00fcllerian hormone levels before and after uterine artery embolization.","volume":"27","author":"McLucas","year":"2017","journal-title":"Minim Invasive Ther Allied Technol"},{"key":"R30-20260520","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1210\/edrv-17-2-121","article-title":"Regulation of ovarian follicular development in primates: facts and hypotheses.","volume":"17","author":"Gougeon","year":"1996","journal-title":"Endocr Rev"},{"key":"R31-20260520","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/aogs.13698","article-title":"The impact of uterine artery embolization on ovarian reserve: a systematic review and meta\u2010analysis.","volume":"99","author":"El Shamy","year":"2019","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R32-20260520","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jvir.2011.01.441","article-title":"Menopause and menopausal symptoms after ovarian artery embolization: a comparison with uterine artery embolization controls.","volume":"22","author":"Hu","year":"2011","journal-title":"J Vasc Interv Radiol"},{"key":"R33-20260520","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/jog.14236","article-title":"Effects of uterine artery occlusion during myomectomy on ovarian reserve: serial follow\u2010up of sex hormone levels, ultrasound parameters and Doppler characteristics.","volume":"46","author":"Chen","year":"2020","journal-title":"J Obstet Gynaecol Res"},{"key":"R34-20260520","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ejogrb.2016.09.001","article-title":"The effects of uterine artery embolization on ovarian reserve.","volume":"206","author":"Kim","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R35-20260520","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1093\/humrep\/dem105","article-title":"Loss of ovarian reserve after uterine artery embolization: a randomized comparison with hysterectomy.","volume":"22","author":"Hehenkamp","year":"2007","journal-title":"Hum Reprod"},{"key":"R36-20260520","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1111\/aogs.15165","article-title":"Quality of life 1 year after uterine artery embolization vs hysterectomy for symptomatic adenomyosis (QUESTA study).","volume":"104","author":"Trommelen","year":"2025","journal-title":"Acta Obstet Gynecol Scand"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045656","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T11:03:10Z","timestamp":1779274990000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":36,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000045656","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"assertion":[{"value":"2025-07-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}